Molecular pathways in colorectal cancer
- PMID: 22694276
- DOI: 10.1111/j.1440-1746.2012.07200.x
Molecular pathways in colorectal cancer
Abstract
Colorectal cancer (CRC) is the second most common newly diagnosed cancer and accounts for the second highest number of cancer related deaths in Australia, the third worldwide and of increasing importance in Asia. It arises through cumulative effects of inherited genetic predispositions and environmental factors. Genomic instability is an integral part in the transformation of normal colonic or rectal mucosa into carcinoma. Three molecular pathways have been identified: these are the chromosomal instability (CIN), the microsatellite instability (MSI), and the CpG Island Methylator Phenotype (CIMP) pathways. These pathways are not mutually exclusive, with some tumors exhibiting features of multiple pathways. Germline mutations are responsible for hereditary CRC syndromes (accounting for less than 5% of all CRC) while a stepwise accumulation of genetic and epigenetic alterations results in sporadic CRC. This review aims to discuss the genetic basis of hereditary CRC and the different pathways involved in the process of colorectal carcinogenesis.
© 2012 Journal of Gastroenterology and Hepatology Foundation and Blackwell Publishing Asia Pty Ltd.
Similar articles
-
Clinical and molecular features of young-onset colorectal cancer.World J Gastroenterol. 2016 Feb 7;22(5):1736-44. doi: 10.3748/wjg.v22.i5.1736. World J Gastroenterol. 2016. PMID: 26855533 Free PMC article. Review.
-
The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer.Gastroenterology. 2007 Jan;132(1):127-38. doi: 10.1053/j.gastro.2006.09.018. Epub 2006 Sep 20. Gastroenterology. 2007. PMID: 17087942
-
[Current concepts in the genetics of hereditary and sporadic colorectal cancer and the role of genetics in clinical practice: sporadic and IBD-associated colorectal tumors, significance of genetic tests in diagnosis, prognosis and assessment of chemotherapy outcome].Orv Hetil. 2006 Mar 12;147(10):449-55. Orv Hetil. 2006. PMID: 16573174 Review. Hungarian.
-
Pathways of colorectal carcinogenesis.Appl Immunohistochem Mol Morphol. 2013 Mar;21(2):97-102. doi: 10.1097/PAI.0b013e31827ea79e. Appl Immunohistochem Mol Morphol. 2013. PMID: 23417071 Review.
-
[Genetic aspects of colorectal carcinogenesis].Wiad Lek. 2004;57(1-2):74-9. Wiad Lek. 2004. PMID: 15181754 Review. Polish.
Cited by
-
Epigenome Chaos: Stochastic and Deterministic DNA Methylation Events Drive Cancer Evolution.Cancers (Basel). 2021 Apr 9;13(8):1800. doi: 10.3390/cancers13081800. Cancers (Basel). 2021. PMID: 33918773 Free PMC article. Review.
-
KRAS and BRAF Mutation Rates and Survival Outcomes in Colorectal Cancer in an Ethnically Diverse Patient Cohort.Int J Mol Sci. 2023 Dec 15;24(24):17509. doi: 10.3390/ijms242417509. Int J Mol Sci. 2023. PMID: 38139338 Free PMC article.
-
HGUE-C-1 is an atypical and novel colon carcinoma cell line.BMC Cancer. 2015 Apr 8;15:240. doi: 10.1186/s12885-015-1183-3. BMC Cancer. 2015. PMID: 25885658 Free PMC article.
-
Regulation of Tumor Initiation by the Mitochondrial Pyruvate Carrier.Cell Metab. 2020 Feb 4;31(2):284-300.e7. doi: 10.1016/j.cmet.2019.11.002. Epub 2019 Dec 5. Cell Metab. 2020. PMID: 31813825 Free PMC article.
-
SMO Inhibition Modulates Cellular Plasticity and Invasiveness in Colorectal Cancer.Front Pharmacol. 2018 Feb 2;8:956. doi: 10.3389/fphar.2017.00956. eCollection 2017. Front Pharmacol. 2018. PMID: 29456503 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical